In this study, we selected the natural product celastrol over other known NFκB inhibitors because it is a potent NFκB inhibitor that has been shown to exert anti-inflammatory effects in vivo [33,34] and neuroprotective effects in animal models of Parkinson's disease and Hungtington's disease [20]. Here, NFKB1 is linked to Parkinson disease.